Wells Fargo & Company Seres Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 200 shares of MCRB stock, worth $176. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Previous 200 -0.0%

Holding current value

$176

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.56 - $1.19 $17,468 - $37,120	-31,194 Reduced 99.36%	200 $0
Q1 2024 May 10, 2024	BUY	$0.75 - $1.56 $2,551 - $5,307	3,402 Added 12.15%	31,394 $24,000
Q4 2023 Feb 09, 2024	SELL	$0.93 - $2.15 $153,721 - $355,377	-165,292 Reduced 85.52%	27,992 $39,000
Q3 2023 Nov 13, 2023	BUY	$2.33 - $5.07 $50,039 - $108,883	21,476 Added 12.5%	193,284 $460,000
Q2 2023 Aug 15, 2023	BUY	$4.67 - $6.55 $545,852 - $765,596	116,885 Added 212.82%	171,808 $822,000
Q1 2023 May 12, 2023	BUY	$4.95 - $6.09 $265,621 - $326,795	53,661 Added 4252.06%	54,923 $311,000
Q4 2022 Feb 13, 2023	SELL	$5.09 - $9.05 $14,822 - $26,353	-2,912 Reduced 69.77%	1,262 $7,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $3,143 - $6,465	898 Added 27.41%	4,174 $26,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.62 $17,334 - $48,920	-6,420 Reduced 66.21%	3,276 $12,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $147,048 - $206,334	-23,341 Reduced 70.65%	9,696 $70,000
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $133,174 - $252,854	-22,122 Reduced 40.11%	33,037 $275,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $142,495 - $589,814	26,098 Added 89.8%	55,159 $384,000
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $584,757 - $771,651	-31,677 Reduced 52.15%	29,061 $693,000
Q1 2021 May 13, 2021	SELL	$17.66 - $28.92 $1.02 Million - $1.67 Million	-57,830 Reduced 48.77%	60,738 $1.25 Million
Q4 2020 Feb 09, 2021	SELL	$23.25 - $37.73 $395,482 - $641,787	-17,010 Reduced 12.55%	118,568 $2.91 Million
Q3 2020 Nov 05, 2020	BUY	$3.74 - $28.74 $146,982 - $1.13 Million	39,300 Added 40.82%	135,578 $3.84 Million
Q2 2020 Aug 13, 2020	BUY	$3.04 - $6.2 $43,903 - $89,540	14,442 Added 17.65%	96,278 $459,000
Q1 2020 May 14, 2020	BUY	$2.64 - $3.82 $216,047 - $312,613	81,836 New	81,836 $292,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $109M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Seres Therapeutics, Inc. Transaction History